Unternehmensprofil · Healthcare

Tibet Rhodiola Pharmaceutical Holding Co

600211 · Shanghai
Land / Region
China
Börsengang
1. Juli 1999
Mitarbeiter
671
Buffett Score
72/100
Stark
Marktkapitalisierung11,72 Mrd. CN¥
Umsatz (TTM)2,89 Mrd. CN¥
EBITDA884,19 Mio. CN¥
Nettomarge33,92 %
ROE21,79 %
KGV (TTM)11,88
Erwartetes KGV135,14
EPS3,06 CN¥
Dividendenrendite5,65 %
52-Wochen-Spanne34,80 CN¥ – 49,94 CN¥

Daten von EODHD, dargestellt in der Berichtswährung; nur zu Informationszwecken, keine Anlageberatung.

Tibet Rhodiola Pharmaceutical Holding Co. produces and sells pharmaceutical products in China and internationally. The company offers modern Tibetan Medicines, including Nodikang capsules and granules, snow mountain golden arhat pain relief film, and ten-flavor Tida capsules; modern Chinese medicines, such as children Shuangqing granules, lipid clearing capsules, ginseng and zhi capsules, puyu capsules, and epilepsy flat film; and recombinant human brain natriuretic peptide for injection. It also provides isosorbide mononitrate sustained-release tablets; and oxygen rhodiola rosea moisturizing essence, secret recipe fragrance powder packet, rhodiola rosea, and Yuan Yang rhodiola rosea moisturizing essence products. In addition, the company offers biopharmaceuticals, traditional Chinese medicine, and chemical drugs for various fields, such as cardiovascular and cerebrovascular diseases, hepatobiliary diseases, orthopedic pain relief, rheumatism, and cold medicines. The company was founded in 1999 and is headquartered in Lhasa, China.

Geschichte

DemnächstDieser Abschnitt wird gerade ergänzt — schauen Sie bald wieder vorbei.

Branchenposition

DemnächstDieser Abschnitt wird gerade ergänzt — schauen Sie bald wieder vorbei.

Noch keine Analysen zu dieser Aktie in Ihrer Sprache.